OTCMKTS:BETRF BetterLife Pharma (BETRF) Stock Price, News & Analysis → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free BETRF Stock Alerts $0.07 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$0.07▼$0.0750-Day Range$0.06▼$0.0852-Week Range$0.03▼$0.09VolumeN/AAverage Volume15,295 shsMarket Capitalization$8.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get BetterLife Pharma alerts: Email Address Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. About BetterLife Pharma Stock (OTCMKTS:BETRF)BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.Read More BETRF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BETRF Stock News HeadlinesApril 15, 2024 | finanznachrichten.deBloom Burton & Co. Inc.: BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 3, 2024 | finance.yahoo.comBetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001April 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.March 4, 2024 | financialpost.comBetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton UniversityMarch 4, 2024 | globenewswire.comBetterLife's 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton UniversityDecember 18, 2023 | finance.yahoo.comBetterLife Announces Closing of a Private PlacementNovember 30, 2023 | finance.yahoo.comBetterLife Announces Extension of WarrantsNovember 15, 2023 | finance.yahoo.comUS Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD DerivativesApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.November 9, 2023 | morningstar.comaTyr Pharma Inc LIFESeptember 14, 2023 | finance.yahoo.comBetterLife Pharma to Host Investors Update Call on September 18, 2023September 12, 2023 | finance.yahoo.comBetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001September 5, 2023 | finance.yahoo.comBetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private PlacementJuly 13, 2023 | finance.yahoo.comBetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private PlacementJune 27, 2023 | finance.yahoo.comBetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD DerivativesJune 22, 2023 | finance.yahoo.comBetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, CanadaJune 9, 2023 | msn.comBetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments ContinueJune 8, 2023 | finance.yahoo.comBetterLife Continues Progress on BETR-001 IND-Enabling StudiesApril 25, 2023 | finance.yahoo.comBetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, CaliforniaApril 24, 2023 | finance.yahoo.comBetterLife Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 20, 2023 | finance.yahoo.comBetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor ConferenceMarch 29, 2023 | proactiveinvestors.comBetterLife Pharma says BETR-001 drug candidate featured in Drug Discovery & Development articleMarch 29, 2023 | finance.yahoo.comBetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development ArticleMarch 22, 2023 | finance.yahoo.comPromise of BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress ArticleMarch 14, 2023 | finance.yahoo.comCORRECTION -- BetterLife Closes $1,857,143 of Private PlacementMarch 14, 2023 | finance.yahoo.comBetterLife Closes $1,857,143 of Private PlacementMarch 13, 2023 | msn.comPsyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & MoreSee More Headlines Receive BETRF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Next Earnings (Estimated)5/28/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:BETRF CUSIPN/A CIK1464165 Webwww.abetterlifepharma.com Phone604-221-0595FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,900,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-446.36% Debt Debt-to-Equity RatioN/A Current Ratio0.08 Quick Ratio0.08 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.05) per share Price / Book-1.49Miscellaneous Outstanding Shares113,820,000Free Float74,248,000Market Cap$8.48 million OptionableNot Optionable Beta1.39 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Ahmad Doroudian Ph.D. (Age 64)Founder, CEO & Chairman Comp: $219.17kMs. Moira Ong C.A. (Age 49)CPA, CA, CFA, Chief Financial Officer Comp: $192.87kDr. Hooshmand Sheshbaradaran Ph.D. (Age 56)Chief Operating Officer Comp: $243.94kDr. Stephen SanghaCorporate Development AdvisorMr. Scott Rudge Ph.D.Head of CMCAnthony Calandra Ph.D.Head of RegulatoryDr. Abdi Ghaffari Ph.D.Head of Preclinical & ToxicologyMore ExecutivesKey CompetitorsBiofronteraNASDAQ:BFRIGalera TherapeuticsNASDAQ:GRTXNuvo PharmaceuticalsOTCMKTS:NRIFFMedicureOTCMKTS:MCUJFASLAN PharmaceuticalsNASDAQ:ASLNView All Competitors BETRF Stock Analysis - Frequently Asked Questions How have BETRF shares performed in 2024? BetterLife Pharma's stock was trading at $0.0480 at the start of the year. Since then, BETRF stock has increased by 55.1% and is now trading at $0.0745. View the best growth stocks for 2024 here. When is BetterLife Pharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024. View our BETRF earnings forecast. How do I buy shares of BetterLife Pharma? Shares of BETRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BETRF) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BetterLife Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.